Pogliani, 2010 Paroxetine and neonatal withdrawal syndrome.

[Altostrata]

As in all cases of this type, the researchers can report only the observable symptoms of neonatal distress. The researchers recommend the newborns "should be followed to assess the long-term effects of prolonged exposure to SSRIs" -- because nobody knows what this may be.

 

BMJ Case Rep. 2010 Apr 29;2010. pii: bcr1220092528. doi: 10.1136/bcr.12.2009.2528.

Paroxetine and neonatal withdrawal syndrome.

Pogliani L, Schneider L, Dilillo D, Penagini F, Zuccotti GV.

 

Source

 

L Sacco Hospital, Department of Pediatrics, Milan, Italy.

 

Abstract and free full text at http://www.ncbi.nlm.nih.gov/pubmed/22736561

 

We report a case of neonatal withdrawal syndrome after in utero exposure to paroxetine 20 mg/day. The infant's symptoms, such as poor neonatal adaptation, respiratory distress, decerebrate posturing, irritability and tremors, commenced soon after birth and persisted for 5 days. All neonates exposed to antidepressants, particularly serotonin reuptake inhibitors (SSRIs), during the last trimester should be followed-up closely for adverse symptoms.

[Barbarannamated]

Very sad.